Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
19.75
-0.08 (-0.40%)
Nov 5, 2025, 4:00 PM EST - Market closed
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.13 billion as of November 5, 2025. Its market cap has increased by 37.44% in one year.
Market Cap
2.13B
Enterprise Value
1.42B
1-Year Change
37.44%
Ranking
Category
Stock Price
$19.75
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.13B, an increase of 202.68%. That is a compound annual growth rate of 15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 2.13B | 56.50% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 849.18B |
| Johnson & Johnson | 448.06B |
| AbbVie | 382.32B |
| UnitedHealth Group | 296.66B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 215.88B |
| Novo Nordisk | 215.64B |